Microbio - Aerobic germs count TSA (water)
Bacterial contamination in pharmaceutical water systems represents the early warning signal that precedes endotoxin accumulation, biofilm formation, and eventual system failure requiring costly sanitization and production disruption. Aerobic bacterial count on water using TSA membrane filtration provides fundamental microbiological assessment for pharmaceutical water systems, medical device manufacturing water, and utility water following Ph. Eur. and USP standards where elevated bacterial counts indicate system contamination requiring investigation and remediation. This culture-based methodology filters water samples through membrane capturing bacteria that TSA incubation cultivates, enabling quantitative colony counting that establishes baseline water quality, detects contamination events, and trends system performance over time. Pharmaceutical water systems producing Purified Water typically maintain action limits of 100 CFU/ml, while Water for Injection demands even lower limits, with regular monitoring demonstrating consistent microbial control essential for regulatory compliance and product quality assurance. Medical device manufacturers using water for final rinsing, cleaning validation, or biocompatibility extraction require low-bioburden water preventing microbial transfer to products. The TSA incubation conditions optimized for common water system organizms - including Pseudomonas species, Burkholderia species, environmental gram-negative bacteria, and biofilm-associated organizms - ensure broad detection capability identifying contamination regardless of organizm type. Water system validation requires bacterial testing at multiple sample points throughout distribution networks, demonstrating that water quality remains acceptable between generation and use points while identifying system areas prone to bacterial colonization requiring design modifications or enhanced maintenance.